Global site English

NYSE: TRIO 61.84 down −0.47 (−0.75%) Close 2 Nov 2026

Chair: Catherine Vos

Audit Committee

Oversees financial reporting, internal controls, the independent auditor, internal audit and the Ethics and Compliance program.

Chair: Ingeborg Lund

Compensation Committee

Sets the pay of the Chairman and CEO and the Executive Committee, and oversees incentive plans and succession.

Chair: Sir David Penhallow

Nominating and Governance Committee

Recommends candidates for the Board, reviews governance practice and leads the annual evaluation of the Board.

Chair: Dr. Rohan Mehta

Science and Technology Committee

Reviews the company’s research portfolio, technology strategy and engineering standards.

Chair: Dame Philippa Ancrum

Systems Safety and Licensing Committee

Established on 27 October 2026. Oversees TriOptimum’s licensed autonomous systems, its maintenance practices, its relationship with the Turing Registry and the independent review announced on 19 October 2026. Meets monthly.

Governance documents and their last revision
DocumentLast revised
Restated Certificate of Incorporation2019-05-16
By-laws2023-05-11
Corporate Governance Guidelines2026-10-27
Charter of the Systems Safety and Licensing Committee2026-10-27
Charters of the Audit, Compensation, Nominating and Governance, and Science and Technology Committees2025-12-11
Code of Conduct2026-10-27
Policy on Related-Party Transactions2022-02-24

Copies of any document are available free of charge from the Corporate Secretary, TriOptimum Corporation, Halsworth Park, Halsworth, England, or at corporate.secretary@trioptimumcorp.com.

The 2026 Annual Meeting was held at Halsworth Park on 14 May 2026. Shareholders elected all eleven directors, approved the compensation of the named executive officers on an advisory basis with 91.4 percent of votes cast, and ratified the appointment of the independent auditor.

The 2027 Annual Meeting is provisionally scheduled for 13 May 2027 at Halsworth Park. Shareholders who wish to propose business or nominate directors should follow the procedures in the By-laws; proposals for inclusion in the 2027 proxy statement must be received by the Corporate Secretary by 27 November 2026.